Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
SNDK
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Skillful Craftsman
EDTK
$15.4M
| $47.7K | ﹤0.01% |
48,600
-14,200
| -23% | -$14.1K |
|
|
MENS
3052
Jyong Biotech
MENS
$157M
| $47.4K | ﹤0.01% |
+22,900
| New | +$48.6K |
|
|
RGNT
3053
Regentis Biomaterials
RGNT
$14.3M
| $47.1K | ﹤0.01% |
+13,348
| New | +$38.1K |
|
3054
Harte-Hanks
HHS
$31.5M
| $46.2K | ﹤0.01% |
21,400
-800
| -4% | -$2.09K |
|
|
YQ
3055
17 Education & Technology Group
YQ
$36.7M
| $45.2K | ﹤0.01% |
20,530
-25,757
| -56% | -$57.9K |
|
3056
Enveric Biosciences
ENVB
$6.36M
| $44.2K | ﹤0.01% |
+32,058
| New | +$77K |
|
3057
TELA Bio
TELA
$37.3M
| $43.6K | ﹤0.01% |
58,100
+5,500
| +10% | +$4.5K |
|
3058
Matinas BioPharma
MTNB
$2.67M
| $43.5K | ﹤0.01% |
71,040
+42,470
| +149% | +$27.4K |
|
|
WYHG
3059
Wing Yip Food Holdings
WYHG
$74M
| $43K | ﹤0.01% |
10,596
+1,496
| +16% | +$4.83K |
|
|
NSRX
3060
Nasus Pharma
NSRX
$45.4M
| $42.7K | ﹤0.01% |
+12,200
| New | +$35.7K |
|
3061
Mercer International
MERC
$25.6M
| $41.3K | ﹤0.01% |
62,511
+46,500
| +290% | +$46.3K |
|
3062
Estrella Immunopharma
ESLA
$27.9M
| $40.7K | ﹤0.01% |
39,100
-23,695
| -38% | -$31K |
|
|
CODX
3063
Co-Diagnostics
CODX
$7.82M
| $38.8K | ﹤0.01% |
+12,500
| New | +$38.5K |
|
3064
Pluri
PLUR
$15.2M
| $38.3K | ﹤0.01% |
18,324
-1,100
| -6% | -$3.15K |
|
3065
Cytosorbents Corp
CTSO
$430M
| $37.4K | ﹤0.01% |
5,001
-35
| -0.7% | -$370 |
|
3066
Metalpha Technology Holding
MATH
$48.5M
| $36.1K | ﹤0.01% |
37,424
-8,676
| -19% | -$9.14K |
|
3067
Oxbridge Re Holdings
OXBR
$11.7M
| $36K | ﹤0.01% |
35,000
+2,300
| +7% | +$2.1K |
|
3068
JE Cleantech Holdings
JCSE
$8.14M
| $35.8K | ﹤0.01% |
+25,230
| New | +$31.9K |
|
3069
Siebert Financial
SIEB
$107M
| $34.6K | ﹤0.01% |
21,000
-800
| -4% | -$1.46K |
|
|
UCL
3070
uCloudlink Group
UCL
$15.3M
| $33.8K | ﹤0.01% |
36,005
-56,950
| -61% | -$64.4K |
|
3071
Pasithea Therapeutics
KTTA
$20M
| $33.8K | ﹤0.01% |
65,600
-27,799
| -30% | -$19.1K |
|
3072
Xos
XOS
$40.9M
| $32K | ﹤0.01% |
+10,600
| New | +$25.9K |
|
|
AMDD
3073
Direxion Daily AMD Bear 1X ETF
AMDD
$20M
| $31K | ﹤0.01% |
1,170
-130
| -10% | -$5.92K |
|
|
TWAV
3074
TaoWeave Inc
TWAV
$5.2M
| $29.5K | ﹤0.01% |
21,400
-38,000
| -64% | -$61K |
|
3075
Neonode
NEON
$15.1M
| $29.3K | ﹤0.01% |
31,168
-16,535
| -35% | -$24.6K |
|
Similar funds
Renaissance Technologies's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Technologies held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Renaissance Technologies's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Renaissance Technologies fully exited Applovin in Q2 2026, selling an estimated $174M.
- Renaissance Technologies's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Renaissance Technologies opened 548 new positions and closed 621 in Q2 2026.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.